Afya Posts Strong FY25 Results: Revenue Up 11.9%, Net Income Jumps 18.4%, Meets Guidance
Summary
Afya Limited reported robust financial results for the fourth quarter and full-year 2025, successfully meeting its revenue and Adjusted EBITDA guidance for the seventh consecutive year. For the full year, revenue increased 11.9% to R$3.7 billion, while net income surged 18.4% to R$768.4 million, with basic EPS growing 18.7%. These strong results, including a 15.4% rise in Adjusted EBITDA, underscore the company's consistent operational execution and the resilience of its medical education and solutions business in Brazil. The sustained performance and guidance achievement are significant positives for investor confidence, especially as the stock trades near its 52-week low. Traders will now look for the company's 2026 guidance to assess future growth prospects and continued financial discipline.
At the time of this announcement, AFYA was trading at $13.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $13.00 to $19.90. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.